


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-1.66%
-5.06%
+10.78%
-2.29%
PACB
Pacific Biosciences
$2.00
Risk Analysis

Earnings are forecast to decrease
Chart
$1.52 (+31.58%)
$1.35 (+48.15%)
$1.16 (+72.41%)
$1.86 (+7.53%)
PACB has Extreme risk level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Price under $5

High volatilty

PACB overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to decrease
![]()
PACB Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
PACB Street view is not attractive and have negative views on the near-term outlook
Average key support and resistance price levels.
Login to displayPACB Earnings
The TTM reflects 12-month period, providing review of PACB financial performance.
The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals
Financial Score
What is PACB current stock price?
What are PACB stock strengths?
What risks are associated with PACB stock?
When is PACB next earnings report?
What is PACB market cap and volume?
What is PACB's current Stock IQ?
Should I buy PACB stock right now?
Is PACB a Strong Buy right now?
What does a 'Strong Buy' rating mean for PACB?
What does a 'Strong Sell' rating mean for PACB?
What factors influence PACB's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-1.66%
-5.06%
+10.78%
-2.29%
PACB
Pacific Biosciences
Current Price
$2.00
Stock Insights
Risk Analysis

Earnings are forecast to decrease

Chart
$1.52 (+31.58%)
$1.35 (+48.15%)
$1.16 (+72.41%)
$1.86 (+7.53%)
PACB Analysts Opinion
PACB Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to decrease
![]()
PACB Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
PACB Street view is not attractive and have negative views on the near-term outlook
PACB has Extreme risk level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Price under $5

High volatilty

Average key support and resistance price levels.
PACB Earnings
The TTM data reflects the most recent 12-month period, providing overview of PACB financial performance.
PACB Financial Health
The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals
Financial Score
PACB Latest Analysis
Pacific Biosciences (PACB) Q3 Earnings on the Horizon: Analysts Insights on Key Performance Measures. Looking beyond Wall Streets top-and-bottom-line estimate forecasts for Pacific Biosciences (PACB) delve into some of its key metrics to gain a deeper insight into the companys potential performance for the quarter ended September 2025.
Today
Pacific Biosciences of California (PACB) Stock Drops Despite Market Gains: Important Facts to Note. Pacific Biosciences of California (PACB) concluded the recent trading session at $1.97 signifying a -5.74% move from its prior days close.
Tue Oct 28, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
PACB Stock trends
PACB Stock performance
PACB Stock analysis
PACB investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.